{"id":17118,"date":"2012-07-21T12:02:25","date_gmt":"2012-07-21T12:02:25","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=17118"},"modified":"2012-07-31T15:11:54","modified_gmt":"2012-07-31T15:11:54","slug":"htb-supplement-2012-pipeline-report","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/17118","title":{"rendered":"HTB supplement: 2012 pipeline report"},"content":{"rendered":"<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright  wp-image-19031\" title=\"pipeline cover\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2012\/07\/pipeline-cover-220x300.png\" alt=\"\" width=\"154\" height=\"210\" srcset=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2012\/07\/pipeline-cover-220x300.png 220w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2012\/07\/pipeline-cover-751x1024.png 751w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2012\/07\/pipeline-cover.png 870w\" sizes=\"auto, (max-width: 154px) 100vw, 154px\" \/>HIV, hepatItIs C vIrus (HCV), and tuberculosIs (TB) drugs, diagnostics, vaccInes, and preventive technologIes in development<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/16872\">Introduction and executive summary<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/16882\">The antiretroviral pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/16891\">The paediatric antiretroviral pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/16894\">Retrofitting for purpose: treatment optimisation<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/16945\">Preventive technologies, research toward a cure, and immune-based and gene therapies<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/16961\">Hepatitis C drug development goes from pony ride to rocket launch<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/16978\">Hepatitis C (HCV) treatment access: spotlight on Thailand\/Asia<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/17053\">The tuberculosis diagnostics pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/17111\">The tuberculosis treatment pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/17115\">The tuberculosis vaccine pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/17175\">Acknowledgments<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>HIV, hepatItIs C vIrus (HCV), and tuberculosIs (TB) drugs, diagnostics, vaccInes, and preventive technologIes in development Introduction and executive summary The antiretroviral pipeline The paediatric antiretroviral pipeline Retrofitting for purpose: treatment optimisation Preventive technologies, research toward a cure, and immune-based &hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,9],"tags":[],"class_list":["post-17118","post","type-post","status-publish","format-standard","hentry","category-editorial","category-special-reports"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/17118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=17118"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/17118\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=17118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=17118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=17118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}